Articles by William Looney - Pharmaceutical Executive


Articles by William Looney

Talent, Terror, and the Turnaround

Jul 1, 2013

Our lead feature this month on 15 new Emerging Pharma Leaders is a window into what makes our publication unique. In 2007, Pharm Exec began a systematic annual search to identify and highlight those men—and women—that in our purely editorial view had real prospects for a future key to the "c suite." Two of our early choices—Sanofi's Chris Viehbacher and Heather Bresch of Mylan—have made it to the very top, as CEO.

Recognizing the Best

Jun 1, 2013

Getting patients to take their medicine on spec and on time is the challenge that never goes away—it's the deadweight baggage accompanying every industry innovation since the arrival of aspirin a century ago.

The Patent Black Label

May 1, 2013

Last month's decision by India's Supreme Court to deny a patent for the top-selling oncologic drug Glivec took nearly a decade of litigation to resolve—but the implications in and beyond India are both immediate and lasting.

The Friendly Persuasion — An Interview with Fred Hassan

May 1, 2013

What is industry icon Fred Hassan's management formula for staying fresh in an era of market churn?

2013 Dealmakers Outlook

Apr 1, 2013

Pharm Exec's annual look at the trends and best practices in biopharm licensing and M&A for the year ahead.

The Community Clause

Apr 1, 2013

The conversation thread that binds this month's Pharm Exec is building communities—when the harsh economics of market change suddenly discounts the familiar, then the best way to move up is to reach out.

Right Board for the Brand

Mar 1, 2013

Pharm Exec's 35-member Editorial Advisory Board met last month to discuss a range of topics, including the influence of other business sectors on pharma's global strategy.

Oncology: Pathways to Progress

Feb 1, 2013

Pharm Exec recently convened a cross-section of industry experts to review current and pending efforts to turn great science into good oncology practice.

In Cancer, Process Drives Progress

Feb 1, 2013

Today's most important public health story is the advance in our understanding of the biology of cancer, writes Pharm Exec Editor-in-Chief William Looney.


Click here